This is a comprehensive presentation of the risks and benefits of radioiodine-131 in the
treatment of metastatic well differentiated thyroid cancer. In addition, methods to optimize the …

Radioiodine long has proven to be a safe and effective treatment for thyroid disease.
Nonetheless, persisting concerns regarding radiogenic stochastic risks (eg, carcinogenesis) …

In calculations of absorbed doses from radioactive patients, the activity distribution in such
patients is generally assumed to be an unattenuated point source and the dose to exposed …

Background: In medical applications of radioisotopes, for calculations of whole body doses
and radiation safety applications, there is a need to estimate radioactive body burden. Local …

Radioiodine (131I iodide) has long been a safe, effective and widely used treatment in the
management of differentiated thyroid cancer (DTC). Concerns regarding stochastic …

US6548042B2 - Bis-phosphonate compounds - Google Patents US6548042B2 - Bis-phosphonate
compounds - Google Patents Bis-phosphonate compounds Download PDF Info Publication …

Spreadsheet templates which calculate cumulative exposures to other persons from patients
to whom radioactive materials have been administered have been developed by the …

Nuclear medicine patients are a source of exposure and should receive instructions to
restrict contact time with different categories of people. The calculation of the restriction time …

The treatment of thyroid cancer generally comprises total thyroidectomy and oral
administration of radioiodine (131I). One consideration in this therapy is the radiation …

Abstract For over 50 years, radioiodine-131 has been used in the post surgical treatment of
differentiated thyroid cancer (1). In 1957, workers at the University of Michigan popularized …